pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 18·1 min read
save

WakeMed and Atrium Health finalize two-year secret merger, sparking local backlash and national attention

May 18, 2026·read at STAT ↗DealNeutral

Hospital executives from WakeMed and Atrium Health worked on a merger in secrecy for two years before announcing the deal. The combination brings together two major health systems in North Carolina, creating a larger network of hospitals and clinics.

The announcement has ignited strong local opposition, with community members expressing anger over the consolidation. Analysts suggest the merger could have broader implications for hospital competition and patient choice across the United States.

The story appears in STAT's Health Care Inc. newsletter, highlighting the financial and strategic dimensions of the deal and its relevance to investors and health‑care professionals.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Why the WakeMed – Atrium Health hospital merger matters”

read at STAT ↗
492 words · retrieved May 18
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
ASTRAZENECA
topics
Approval4Hypertension

related stories

  • Sep 23Amgen asset from $27.8B Horizon buy scores in Phase 3 Sjögren's studyBioSpace
  • Sep 22Amgen’s Horizon-acquired fusion protein eases Sjögren's severity in ph. 3 winFierce Biotech
  • Sep 8Roivant surges on ‘exceptional’ results; Bristol Myers touts first-of-its-kind CAR-T therapyBioPharma Dive
  • Sep 8STAT+: FDA approves AstraZeneca breast cancer drugSTAT
  • Aug 17STAT+: Akeso and Summit’s lung cancer drug shows worsening tumor-progression benefitSTAT